Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
Find a doctor at The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center or Johns Hopkins Community Physicians.
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Current News Releases
Current News Releases
Study clarifies tie between cysteine deficiency and Huntington’s disease
Researchers at Johns Hopkins Medicine report they have identified a biochemical pathway linking oxidative stress and the amino acid cysteine in Huntington’s disease. The findings, described in last week’s issue of the Proceedings of the National Academy of of Sciences, provide a mechanism through which oxidative stress specifically damages nerve cells in Huntington’s disease, an inherited and fatal neurodegenerative disorder.
The Damon Runyon Cancer Research Foundation has named two Johns Hopkins trainees winners of the Damon Runyon-Sohn Pediatric Fellowship Award. This fellowship provides funding to basic scientists and clinicians who conduct research to fight one or more pediatric cancers. The recipients will receive a four-year award for a total of $248,000.
Project provides a model for innovative health research, care and wellness
The Maryland-based health care informatics company CTIS and its founders, Raj and Bharti Shah, have collaborated with the Johns Hopkins Center for Clinical Global Health Education and Byramjee Jeejeebhoy Government Medical College to equip and dispatch a custom-designed mobile health care services van in the state of Maharashtra in India.
In research using patient medical records, investigators from Johns Hopkins and Sheppard Pratt Health System report that people with serious mental disorders who were hospitalized for mania were more likely to be on antibiotics to treat active infections than a group of people without a mental disorder.
Mobilizing the physician query process with Artifact Health
Artifact Health Inc., a leading innovator in physician-centric clinical documentation improvement (CDI) solutions, today announced a collaboration with Johns Hopkins Medicine to bring to market a cloud-based mobile application for physicians that leverages the expertise of CDI specialists and medical coders to capture a more complete picture of a patient’s health.
A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts.
Tips and guidelines to ensure you get a restful sleep
We have all had those mornings and nights: the ones where you wake up feeling groggy and completely unrested, or where you toss and turn relentlessly. Have you ever wondered if there were things you could do to limit these feelings? Our experts have some tips and guidelines on getting your most restful sleep and waking up rejuvenated.
Study of new 'liquid biopsy' conducted on Australian patients
Scientists at the Johns Hopkins Kimmel Cancer Center and University of Melbourne report they have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
In a look-back study of medical records, researchers at Johns Hopkins Medicine concluded that a major operation to fuse the spines of children with a rare form of severe, early-onset scoliosis can be eliminated in many cases.
Richard Huganir, Ph.D., has been appointed the next president of the Society for Neuroscience, a 38,000-member professional society for researchers who focus on the brain and nervous system. His term will run from 2017 to 2018.
Experiments shed light on how “plaques” and “tangles” interact and take hold
Using a novel, newly developed mouse model that mimics the development of Alzheimer’s disease in humans, Johns Hopkins researchers say they have been able to determine that a one-two punch of major biological “insults” must occur in the brain to cause the dementia that is the hallmark of the disease. A description of their experiments is published online in the journal Nature Communications.
Mouse studies of “asymmetric division” of immune T cells may also shed light on how stem cells differentiate
When an immune T cell divides into two daughter cells, the activity of an enzyme called mTORC1, which controls protein production, splits unevenly between the progeny, producing two cells with different properties. Such “asymmetric division,” uncovered by Johns Hopkins Kimmel Cancer Center researchers using lab-grown cells and specially bred mice, could offer new ways to enhance cancer immunotherapy and may have other implications for studying how stem cells differentiate.
Pablo Celnik, M.D. has been appointed director of the Department of Physical Medicine and Rehabilitation at Johns Hopkins. He had served in the position in an interim capacity for the past 18 months. Celnik will also serve as physiatrist-in-chief for The Johns Hopkins Hospital and the Lawrence Cardinal Shehan Professor of Physical Medicine and Rehabilitation.
Proteogenomics provides new inroads to diagnosis, treatment
In what is believed to be the largest study of its kind, scientists at the Johns Hopkins University and the Pacific Northwest National Laboratory led a study that examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumors
Man-made breast milklike sugar shown to treat lung damage in mice
Johns Hopkins researchers report they have figured out a root cause of the lung damage that occurs in up to 10 percent of premature infants who develop necrotizing enterocolitis, a disorder that damages and kills the lining of the intestine.
In a small study to determine the best way to assess the operating skills of would-be orthopaedic surgeons, Johns Hopkins researchers found that tracking the trainees’ performance on cadavers using step-by-step checklists and measures of general surgical skills works well but should be coupled with an equally rigorous system for tracking errors.
Study points to potential of drug target
Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson’s disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder’s presence and progression.
Johns Hopkins researchers find that the bacteria in our mouths could be a tool for finding and fighting cancer
In a sample study, researchers at Johns Hopkins say they have found an association between the makeup of an individual’s microbiome and head and neck cancer, a finding that potentially advances the quest for faster and more accurate cancer diagnosis and therapy.
Emetime appears to stop replication of a herpesvirus
Researchers at Johns Hopkins have found that an old drug once mostly used to treat amebiasis — a disease caused by a parasite — and induce vomiting in cases of poisoning appears to also halt replication of cytomegalovirus (CMV), a herpesvirus that can cause serious disease in immunocompromised individuals, including those with HIV or organ transplant recipients.
Using so-called next-generation genome sequencing, researchers at Johns Hopkins have identified 84 potential inherited gene mutations that may contribute to the most severe forms of bipolar disorder. About 5.6 million Americans are estimated to have bipolar disorder.